Companies / New York / TNF Pharmaceuticals

· rebuilt nightly from public records

Signal Sheet

Selling to TNF Pharmaceuticals? Who to reach and why now

Headquartered in New York, New York, TNF Pharmaceuticals is a publicly listed in vitro & in vivo diagnostic substances company, founded 2023. It raised $7M in Sep 2025 and its filings name 7 officers. Everything below links to the record it came from.

Listed company · In Vitro & In Vivo Diagnostic Substances · New York

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerIan RhodesSEC filing, Sep 2025Named officer in the filing; part of the buying group
Executive OfficerJoshua SilvermanSEC filing, Sep 2025Named officer in the filing; part of the buying group
Executive OfficerMitchell GlassSEC filing, Sep 2025Named officer in the filing; part of the buying group
Chief Technology OfficerChristopher SchreiberSEC filing, Sep 2025Technology and tooling decisions
Chief Technology OfficerBruce BernsteinSEC filing, Sep 2025Technology and tooling decisions
Chief Technology OfficerBill J. WhiteSEC filing, Sep 2025Technology and tooling decisions
Chief Technology OfficerStephen FrisciaSEC filing, Sep 2025Technology and tooling decisions
For sellersWhy TNF Pharmaceuticals is worth a call this quarterBuy Window: open · major agreement Sep 2026
Sep 2026Sep 2026

Corporate event

Signed a material agreement

Corporate event
Sep 14Sep 2026

New leadership

Officer or director change

New leadership
$7M

Raised

Equity raise reported to the SEC, Sep 2025. Money arrives before the spending plan does.

Capital
Track TNF Pharmaceuticals with a free trial →Get the next signal the day it is filed or posted.
Email me the next TNF Pharmaceuticals signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Sep 14, 2026Signed a material agreementCorporate eventSEC filing
Sep 14, 2026Officer or director changeNew leadershipSEC filing
Sep 10, 2026Officer or director changeNew leadershipSEC filing
Sep 2, 2025Raised $7M in equity from 12 investorsCapitalSEC filing

Reach TNF Pharmaceuticals with emails that land

Lakewave finds the right people at TNF Pharmaceuticals, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on TNF Pharmaceuticals with a free trial →

About TNF Pharmaceuticals

HeadquartersNew York, New York, per the filing address
Industry groupIn Vitro & In Vivo Diagnostic Substances
Founded2023, DE
OwnershipListed company
Raise history$7M (Sep 2025)

Questions people ask

Did TNF Pharmaceuticals raise funding in 2025?

Yes. TNF Pharmaceuticals reported a $7M equity raise to the SEC on Sep 2, 2025 with 12 investors.

Who runs TNF Pharmaceuticals?

The company's SEC filing, Sep 2025 names Ian Rhodes (Executive Officer) among its officers.

Where is TNF Pharmaceuticals headquartered?

New York, New York, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.